全文获取类型
收费全文 | 318篇 |
免费 | 10篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 7篇 |
妇产科学 | 6篇 |
基础医学 | 21篇 |
口腔科学 | 2篇 |
临床医学 | 41篇 |
内科学 | 71篇 |
皮肤病学 | 1篇 |
神经病学 | 17篇 |
特种医学 | 24篇 |
外科学 | 77篇 |
综合类 | 6篇 |
预防医学 | 28篇 |
眼科学 | 9篇 |
药学 | 4篇 |
肿瘤学 | 13篇 |
出版年
2023年 | 1篇 |
2022年 | 1篇 |
2021年 | 4篇 |
2020年 | 7篇 |
2019年 | 8篇 |
2018年 | 6篇 |
2017年 | 5篇 |
2016年 | 8篇 |
2015年 | 3篇 |
2014年 | 2篇 |
2013年 | 10篇 |
2012年 | 12篇 |
2011年 | 11篇 |
2010年 | 8篇 |
2009年 | 4篇 |
2008年 | 9篇 |
2007年 | 11篇 |
2006年 | 12篇 |
2005年 | 14篇 |
2004年 | 10篇 |
2003年 | 11篇 |
2002年 | 14篇 |
2001年 | 7篇 |
2000年 | 3篇 |
1999年 | 5篇 |
1998年 | 6篇 |
1997年 | 1篇 |
1996年 | 2篇 |
1995年 | 5篇 |
1994年 | 3篇 |
1993年 | 4篇 |
1992年 | 16篇 |
1991年 | 15篇 |
1990年 | 4篇 |
1989年 | 10篇 |
1988年 | 13篇 |
1987年 | 15篇 |
1986年 | 15篇 |
1985年 | 7篇 |
1984年 | 7篇 |
1983年 | 9篇 |
1982年 | 4篇 |
1981年 | 1篇 |
1979年 | 1篇 |
1970年 | 2篇 |
1969年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有328条查询结果,搜索用时 15 毫秒
81.
J Ikezoe S Sone T Higashihara S Morimoto J Arisawa K Kuriyama Y Monden K Nakahara T Azuma S Machi 《European journal of radiology》1986,6(1):65-66
We recently encountered a tracheal schwannoma presenting as a polypoid mass. Computed tomography (CT) was very effective in evaluation of the size, shape and site of this rare tumour. Furthermore, CT images in the prone position made it easy to exclude tumour extension into the mediastinum. 相似文献
82.
83.
H Funada T Machi T Matsuda 《Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases》1989,63(8):874-879
We experienced 57 episodes of Pseudomonas aeruginosa bacteremia in 55 patients with hematologic disorders such as acute leukemia over a 16-year period. All the patients were treated on the same hospital ward. A total of 57 blood culture isolates of P. aeruginosa were divided into nine serogroups. Seventy-four percent of the isolates belonged to four serogroups, which became preponderant one after the other. Surveillance throat and/or stool cultures grew the organisms identical to the isolates from the blood at or prior to the onset of bacteremia in 75% of the episodes. Only 11% of the patients had had P. aeruginosa cultured at admission. The acquisition of the organism was closely associated with antibiotic therapy for other presumed or proved infection. On the other hand, 60% of the episodes occurred during the administration of at least one in vitro effective antibiotic. In five episodes, the patients had received an antipseudomonal penicillin and an aminoglycoside in combination, both of which proved effective in vitro against the infecting organism, when bacteremia occurred. In managing P. aeruginosa bacteremia complicating hematologic disorders, it was thus suggested that surveillance cultures should be regularly carried out, and that attention should be drawn to the occurrence of "breakthrough" bacteremia. 相似文献
84.
Machi Okamoto Hideya Sakakibara Hiroshi Yoshida Yuka Fukazawa Kunitomo Takashima Yoshihito Kondo Mario Ikeda Masahiko Ishikawa Fumiki Hirahara 《Reproductive Medicine and Biology》2010,9(4):191-195
Purposes
It is sometimes difficult to restore a regular ovulatory cycle in women with polycystic ovary syndrome (PCOS) using classic agents such as clomiphene citrate or gonadotropins. Saireito, a herbal medicine, is believed to have an effect similar to corticosteroids. We examined the effect of Saireito on ovulatory induction and endocrine status in women with PCOS. 相似文献85.
Paolo Machi Arthur J. Ulm Gianmarco Bernava Olivier Brina Karl Olof Lovblad Franck Jourdan 《Journal of neuroradiology. Journal de neuroradiologie》2019,46(3):163-167
Background and purpose
Stent retrievers are recognized as the most effective devices for intracranial thrombectomy. Although highly effective, such devices fail in clot removal when the brain vessel occlusion is due to organized, firm clots. The mechanism of failure is that during the retrieval, devices remain compressed by the organized clot and slide between it and the vessel wall without any removal effect. The aim of the current study is to present the preclinical evaluation of the Neva? device, a novel stent retriever designed to improve the incorporation and removal of organized thrombi.Materials and methods
Preclinical evaluation of the Neva? device was divided in three main chapters: efficacy analysis, mechanical analysis and safety analysis. Efficacy and mechanical analysis aimed to investigate the behavior during the retrieval of the Neva? device and its interaction with experimental organized clots. Safety analysis was conducted on animals in order to investigate the effect of the Neva? device on real arteries after simulated thrombectomy maneuvers.Results
Neva? device showed a high rate of “optimal clot integration” and “effective clot removal” which was related to constant cohesion to the vessel wall during retrievals. Safety analysis showed as the most frequent finding the disruption of the intima of the tested vessels with, in some cases, minimal disruption of the internal elastic lamina.Conclusions
The Neva? device has demonstrated safety and efficacy in a pre-clinical study. Such encouraging, preliminary results have to be compared with those of clinical trials. 相似文献86.
87.
Based on the prevalence of musculoskeletal pain in the context of interference with daily activities (IDA) and treatment for musculoskeletal disorders in the study population (n = 3188), we estimated the prevalence and years lived with disability (YLD) of musculoskeletal pain in Japan. The total of 42287 thousand (41.2%) of Japanese adult people was estimated to suffer from musculoskeletal pain. Among them, 9127 thousand was estimated to interfere with daily activities due to the pain. Overall YLD for musculoskeletal pain in Japan were estimated at 1297843.7 (1263.6 per 100000). The YLD for Pain without IDA were 33159.3 (32.3 per 100000) and the YLD for Pain with IDA were 1264684.4 (1231.3 per 100000). One-way sensitivity analysis showed that the YLD of musculoskeletal pain might increase to 4421844.0 (4305.2 per 100000) with the increased disability weight for Pain without IDA of 0.1, while they might inversely decrease to 1018875.0 (992.0 per 100000) with the increased treatment rate in Pain with IDA of 100%. Musculoskeletal pain imposes a substantial burden on the Japanese adult population. To allow the population to keep their health-related quality of life, health professionals should pay more attention to musculoskeletal pain and make positive efforts to improve prevention and control of musculoskeletal pain. 相似文献
88.
F. Danire K. Lobotesis P. Machi O. Eker I. Mourand C. Riquelme X. Ayrignac J.F. Vendrell G. Gascou J. Fendeleur C. Dargazanli R. Schaub H. Brunel C. Arquizan A. Bonaf V. Costalat 《AJNR. American journal of neuroradiology》2015,36(1):32
BACKGROUND AND PURPOSE:The purpose of this study was to evaluate the benefits of endovascular intervention in large-vessel occlusion strokes, depending on age class.MATERIALS AND METHODS:A clinical management protocol including intravenous treatment and mechanical thrombectomy was instigated in our center in 2009 (Prognostic Factors Related to Clinical Outcome Following Thrombectomy in Ischemic Stroke [RECOST] study). All patients with acute ischemic stroke with an anterior circulation major-vessel occlusion who presented within 6 hours were evaluated with an initial MR imaging examination and were analyzed according to age subgroups (younger than 50 years, 50–59 years, 60–69 years, 70–79 years; 80 years or older). The mRS score at 3 months was the study end point.RESULTS:One hundred sixty-five patients were included in the analysis. The mean age was 67.4 years (range, 29–90 years). The mean baseline NIHSS score was 17.24 (range, 3–27). The mean DWI-derived ASPECTS was 6.4. Recanalization of TICI 2b/3 was achieved in 80%. At 3 months, 41.72% of patients had a good outcome, with a gradation of prognosis depending on the age subgroup and a clear cutoff at 70 years. Only 19% of patients older than 80 years had a good outcome at 3 months (mean ASPECTS = 7.4) with 28% for 70–79 years (mean ASPECTS = 6.8), but 58% for 60–69 years (mean ASPECTS = 6), 52% for 50–59 years (mean ASPECTS = 5.91), and 72% for younger than 50 years (mean ASPECTS = 6.31). In contrast, the mortality rate was 35% for 80 years and older, and 26% for 70–79 versus 5%–9% for younger than 70 years.CONCLUSIONS:The elderly may benefit from thrombectomy when their ischemic core volume is low in comparison with younger patients who still benefit from acute recanalization despite larger infarcts. Stroke volume thresholds should, therefore, be related and adjusted to the patient''s age group.Ischemic stroke is the third leading cause of death in France (fourth in the United States1,2), leading to significant disability.3 The World Health Organization predicts an increasing number of strokes in Europe during the next 10 years.4 Intravenous recombinant tissue plasminogen activator for cerebral arterial occlusion is the established therapy to date for acute ischemic stroke. The odds ratio benefit is 1.28–1.7 for a favorable outcome versus a placebo5,6 within 4.5 hours after stroke onset. Initially, being older than 80 years of age was established as a bad prognostic factor in intravenous treatment7–10 and even considered an exclusion criterion.5 Today, this statement is seen as controversial, with recent studies having shown that elderly patients would still benefit from IV tPA.11,12 In addition, new therapeutic strategies in stroke units are increasingly involving adjunctive endovascular techniques when fibrinolysis is contraindicated or has failed or when large and proximal intracranial vessels are occluded.13–17 Previous studies have shown that mechanical thrombectomy by using Stentrievers (Trevo; Stryker, Kalamazoo, Michigan), in particular new stent retrievers,18 was successful in achieving a high rate of arterial recanalization and favorable clinical outcome in large-vessel occlusion.19–21 Nevertheless, inclusion and exclusion criteria for these new invasive strategies are still being evaluated and may need to be optimized to avoid futile recanalization, particularly for fragile patients. The purpose of this study was to investigate the benefits and safety of these new recanalization devices according to age subgroups. 相似文献
89.
Masaki Ueno Yoichi Chiba Koichi Matsumoto Ryuta Murakami Ryuji Fujihara Machi Kawauchi Hiroshi Miyanaka Toshitaka Nakagawa 《Neuropathology》2016,36(2):115-124
New findings on flow or drainage pathways of brain interstitial fluid and cerebrospinal fluid have been made. The interstitial fluid flow has an effect on the passage of blood‐borne substances in the brain parenchyma, especially in areas near blood‐brain barrier (BBB)‐free regions. Actually, blood‐borne substances can be transferred in areas with intact BBB function, such as the hippocampus, the corpus callosum, periventricular areas, and medial portions of the amygdala, presumably through leaky vessels in the subfornical organs or the choroid plexus. Increasing evidence indicates that dysfunction of the BBB function may play a significant role in the pathogenesis of vascular dementia. Accordingly, we have examined which insults seen in patients suffering from vascular dementia have an effect on the BBB using experimental animal models exhibiting some phenotypes of vascular dementia. The BBB in the hippocampus was clearly deteriorated in Mongolian gerbils exposed to acute ischemia followed by reperfusion and also in stroke‐prone spontaneously hypertensive rats (SHRSP) showing hypertension. The BBB in the corpus callosum was clearly deteriorated in Wistar rats with permanent ligation of the bilateral common carotid arteries showing chronic hypoperfusion. The BBB in the hippocampus and the olfactory bulb was mildly deteriorated in aged senescence accelerated prone mice (SAMP8) showing cognitive dysfunction. The BBB in the hippocampus was mildly deteriorated in aged animals with hydrocephalus. Mild endothelial damage was seen in hyperglycemic db/db mice. In addition, mRNA expression of osteopontin, matrix metalloproteinase‐13 (MMP‐13), and CD36 was increased in vessels showing BBB damage in hypertensive SHRSP. As osteopontin, MMP‐13 and CD36 are known to be related to brain injury and amyloid β accumulation or clearance, BBB damage followed by increased gene expression of these molecules not only contributes to the pathogenesis of vascular dementia, but also bridges the gap between vascular dementia and Alzheimer's disease. 相似文献
90.
Nonsense and missense mutations in the human hepatocyte nuclear factor-1 beta gene (TCF2) and their relation to type 2 diabetes in Japanese 总被引:2,自引:0,他引:2